CUSP Comments on Continued Misapplication of Opioid Prescribing Guidelines
CUSP urges CDC to address misinterpretations of the opioid prescribing
guideline and take corrective action.
Institute Launches Nat’l Recovery Friendly Workplace Certification
The National Recovery Friendly Workplace Institute has created a national
Recovery Friendly Workplace certification program for employers.
CUSP Supports FDA Data Improvement Plan
CUSP sends letter supporting FDA’s plan to improve substance misuse data collection, highlighting the crucial role of the RADARS System in addressing substance misuse.
The Role of Compliance Plans in Opioid Prescribing
Medpage Today discusses opioid prescribing challenges, emphasizing legal fears and advocating for compliance plans with potential patient benefits.
Special Edition of JOM Focuses on Opioid Law and Policy
The Journal of Opioid Management has released a special edition on pain management and opioid misuse, titled "Legal, Legislative, and Regulatory Approaches to Reducing Opioid Use Disorder and Opioid-Involved Poisonings."
FDA Denies Citizen Petition to Protect Patients
Inside Health Policy covers FDA’s denial of CUSP’s Citizen Petition urging the FDA to recall a software that influences the prescribing of controlled medications.
FDA Denial of Petition to Protect Marginalized Patients
The FDA has denied CUSP’s Citizen Petition aimed at protecting patients from being deprived of the prescription drugs they need.
FDA Should Recall Software to Protect Patients
Axios reports on CUSP’s citizen petition asking the FDA to recall a widely used clinical decision support software.
Health Policy Advocates Oppose Federal Opioid Treatment Bill
Health policy advocates oppose federal opioid treatment bill to "authorize" methadone dispensing in pharmacies.
Health Policy Advocates Petition FDA to Recall Software
Inside Health Policy reports on CUSP’s Citizen Petition urging the FDA to initiate a recall of a widely-used clinical decision support software.
